Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs.

OBJECTIVE Assess predictors and costs of various types of alternative medicine used by adult patients with cancer. DESIGN, LOCATION, SUBJECTS: Telephone survey of 356 patients with colon, breast, or prostate cancer identified from the population-based Cancer Surveillance System of western Washington. RESULTS Overall, 70.2% of patients used at least one type of alternative medicine, with 16.6% seeing alternative providers, 19.1% using mental/other therapy, and 64.6% taking dietary supplements. Compared to males, females were five times more likely to see an alternative provider and about twice as likely to use mental therapies or supplements (p < 0.05 for all). Older patients were less likely to use mental/other therapy. Higher education (but not income) was associated with use of all types of alternative medicine. Patients with multiple medical treatments were two times more likely to take dietary supplements compared to patients having only surgery (p < 0.01). Varying by the type of alternative therapy, 83%-97% of patients reported that they used alternative medicine for general health and well-being while 8% to 56% reported use for treatment of cancer. Almost all patients reported that the alternative therapy improved their well-being. Expenditures for alternative medicine averaged $68 per user per year, but ranged from $4 to $14,659. CONCLUSIONS Given the high prevalence of use and that patients believed that alternative medicine improved their well-being, clinicians should show an open mind toward these treatment choices and encourage frank discussion. Familiarity and some knowledge regarding use of alternative medicine is important in cases where interactions between conventional and alternative medicine may occur. It is also important to identify potential patient needs for mental health support beyond conventional care and support patients who want to make healthful lifestyle changes. Longitudinal investigations are urgently needed to investigate associations of alternative medicine use with survival and quality of life in patients with cancer.

[1]  R. Kessler,et al.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use. , 1993, The New England journal of medicine.

[2]  B. Cassileth,et al.  Alternative and complementary cancer therapies , 1996, Cancer.

[3]  L. G. Miller,et al.  Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. , 1998, Archives of internal medicine.

[4]  Cheryl L. Rock,et al.  Dietary Supplement Use by Women at Risk for Breast Cancer Recurrence , 1998 .

[5]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[6]  E. Ernst The prevalence of complementary/Alternative medicine in cancer , 1998, Cancer.

[7]  D. Lamson,et al.  Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. , 1999, Alternative medicine review : a journal of clinical therapeutic.

[8]  A. Vickers,et al.  What is complementary medicine? , 1999, BMJ.

[9]  R. Livingston,et al.  Possible interactions between dietary antioxidants and chemotherapy. , 1999, Oncology.

[10]  B. Hankey,et al.  The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  R B Ervin,et al.  Use of dietary supplements in the United States, 1988-94. , 1999, Vital and health statistics. Series 11, Data from the National Health Survey.

[12]  E. Guadagnoli,et al.  Use of alternative medicine by women with early-stage breast cancer. , 1999, The New England journal of medicine.

[13]  M. Stewart,et al.  Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Singletary,et al.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Söllner,et al.  Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior , 2000, Cancer.

[16]  E. Walters,et al.  Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United States , 2001, Annals of Internal Medicine.

[17]  A. Williams,et al.  Nutrition During and After Cancer Treatment: A Guide * for Informed Choices by Cancer Survivors , 2001, CA: a cancer journal for clinicians.

[18]  T. Kaptchuk,et al.  Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey , 2001, Annals of Internal Medicine.

[19]  [Drug-induced liver injury]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[20]  O. Brawley Nonmedical factors in treatment selection. , 2003, The Urologic clinics of North America.

[21]  C. Cheney,et al.  The association between vitamin C and vitamin E supplement use before hematopoietic stem cell transplant and outcomes to two years. , 2003, Journal of the American Dietetic Association.